Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- DRUG: 4-month rifapentine-based regimen
Sponsor
Kaohsiung Veterans General Hospital.
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]